Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Benlysta nod should benefit remaining lupus prospects

Thursday, March 10th, 2011

FDA's approval of Benlysta is indeed an historic moment for lupus patients, a community that has waited 50 years for a new treatment. The milestone, however, may have even bigger ramifications going forward. The door for additional – and perhaps more effective – new drugs for the autoimmune disorder has suddenly ...

Posted in antibodies, clinical trials, drug discovery | No Comments »

Lupus drought: 50 years and counting

Thursday, October 8th, 2009

In this month’s issue of R&D Directions, we examine the 10 most active areas of therapeutic research, and also highlight some promising therapies for diseases in these categories. One condition researchers are particularly hesitant to lump into that “promising” group is lupus – and who could blame them? There have ...

Posted in Uncategorized, antibodies, clinical trials | 1 Comment »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2012 UBM Canon